Effects of buprenorphine on shock titration in squirrel monkeys
- PMID: 4045722
Effects of buprenorphine on shock titration in squirrel monkeys
Abstract
The effects of buprenorphine were examined under a shock titration procedure and compared to the effects of morphine. Under this procedure shock increased every 15 sec from 0 to 2.0 mA in 30 increments. Five responses within a 15-sec shock period decreased shock intensity by one increment. Both buprenorphine and morphine increased the level at which shock was maintained without decreasing rates of responding in the presence of shock. Buprenorphine-induced increases in median shock level occurred over a 10-fold dose range and were apparent for 6 to 12 hr. Dose-effect curves for morphine and buprenorphine were shifted to the right by prior administration of diprenorphine (0.001-1.0 mg/kg), naloxone (0.001-1.0 mg/kg) and beta-funaltrexamine (1.0-16.0 mg/kg), with the dose of antagonist required to restore responding to control levels being 1 to 2 log U larger for buprenorphine than for morphine. Buprenorphine-induced increases in median shock level were also restored to control levels when naloxone (1.0 mg/kg) was administered as much as 110 min after buprenorphine. Buprenorphine was not effective in antagonizing the effects of morphine. When a dose of buprenorphine which increased median shock level was administered once daily, median shock levels returned to control level within 6 to 15 days. When the morphine dose-effect curve was then redetermined in the presence of chronic buprenorphine, it exhibited a 10-fold shift to the right.
Similar articles
-
Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.J Pharmacol Exp Ther. 1983 Aug;226(2):317-23. J Pharmacol Exp Ther. 1983. PMID: 6875844
-
Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey.J Pharmacol Exp Ther. 1984 Mar;228(3):669-75. J Pharmacol Exp Ther. 1984. PMID: 6707916
-
Effects of morphine, pentazocine and cyclazocine alone and in combination with naloxone on electric shock titration in the squirrel monkey.J Pharmacol Exp Ther. 1979 Dec;211(3):722-32. J Pharmacol Exp Ther. 1979. PMID: 117098
-
Limitations on the antagonistic actions of opioid antagonists.Fed Proc. 1982 May;41(7):2333-8. Fed Proc. 1982. PMID: 7042396 Review.
-
Buprenorphine.Conn Med. 1988 May;52(5):285-7. Conn Med. 1988. PMID: 3042275 Review. No abstract available.
Cited by
-
Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.J Pharmacol Exp Ther. 2011 Feb;336(2):488-95. doi: 10.1124/jpet.110.173823. Epub 2010 Nov 4. J Pharmacol Exp Ther. 2011. PMID: 21051498 Free PMC article.
-
Kappa antagonist properties of buprenorphine in non-tolerant and morphine-tolerant rats.Psychopharmacology (Berl). 1989;98(1):141-3. doi: 10.1007/BF00442021. Psychopharmacology (Berl). 1989. PMID: 2543017
-
Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.Life Sci. 2009 Aug 12;85(7-8):309-15. doi: 10.1016/j.lfs.2009.06.006. Epub 2009 Jun 24. Life Sci. 2009. PMID: 19559034 Free PMC article.
-
Operant nociception in nonhuman primates.Pain. 2014 Sep;155(9):1821-1828. doi: 10.1016/j.pain.2014.06.010. Epub 2014 Jun 23. Pain. 2014. PMID: 24968803 Free PMC article.
-
Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.Psychopharmacology (Berl). 1990;102(4):465-73. doi: 10.1007/BF02247126. Psychopharmacology (Berl). 1990. PMID: 1965748